Perspectiva histórica de la oncología gastrointestinal
DOI:
https://doi.org/10.56050/01205498.2177Palabras clave:
tumor, neoplasia, gastrointestinal, historiaResumen
La historia de la oncología gastrointestinal está atada a la de la oncología en general. Desde los primeros conocimientos sobre la enfermedad, pasando por los desarrollos de las técnicas quirúrgicas hasta el conocimiento de la fisiopatología celular y molecular, la oncología gastrointestinal muestra el desarrollo que han tenido las distintas disciplinas para el entendimiento y control del cáncer. Las mejoras en la detección temprana han tenido de igual forma impacto trascendental no solo en los resultados sino en el entendimiento y el abordaje la patología gastrointestinal oncológica. La historia de la oncología gastrointestinal está muy influenciada por el desarrollo del conocimiento y tratamiento de dos enfermedades: el cáncer colorrectal y el cáncer gástrico, varios de sus avances son la base del abordaje de las distintas neoplasias del tracto gastrointestinal e incluso de otros tumores de distinto origen.
Biografía del autor/a
Leonardo Rojas, Clínica Colsanitas
Referencias bibliográficas
Mulcahy HE, Hyland J, O’Donoghue DP. From dinosaurs to DNA: a history of colorectal cancer. Int J Colorectal Dis. 2003;18(3):210-215.
Menendez P, Padilla D, Villarejo P, Menendez JM, Rodriguez Montes JA, Martin J. [Historical aspects of neoplastic diseases: colorectal cancer]. Gastroenterol Hepatol. 2010;33(7):541-546.
Vargas A, López M, Lillo C, Vargas MJ. [The Edwin Smith papyrus in the history of medicine]. Rev Med Chil. 2012;140(10):1357-1362.
Sánchez Gonzales MA. Historia, teoría y método de la medicina: introducción al pensamiento médico. Barcelona 1998.
Gallucci BB. Selected concepts of cancer as a disease: from 1900 to oncogenes. Oncol Nurs Forum. 1985;12(5):69-78.
Tan SY, Yeow ME. John Hunter (1728 - 1793): founder of scientific surgery. Singapore Med J. 2004;45(5):196- 198.
Galler AS, Petrelli NJ, Shakamuri SP. Rectal cancer surgery: a brief history. Surg Oncol. 2011;20(4):223- 230.
Lange MM, Rutten HJ, van de Velde CJ. One hundred years of curative surgery for rectal cancer: 1908-2008. Eur J Surg Oncol. 2009;35(5):456-463.
Cotlar AM. Historical landmarks in operations on the colon--surgeons courageous. Curr Surg. 2002;59(1):91-95.
Hajdu SI. A note from history: Rudolph Virchow, pathologist, armed revolutionist, politician, and anthropologist. Ann Clin Lab Sci. 2005;35(2):203-205.
Zhang CD, Yamashita H, Seto Y. Gastric cancer surgery: historical background and perspective in Western countries versus Japan. Ann Transl Med. 2019;7(18):493.
Groves EW. On the Radical Operation for Cancer of the Pylorus: With Especial Reference to the Advantages of the Two-Stage Operation and to the Question of the Removal of the Associated Lymphatics. Br Med J. 1910;1(2563):366-370.
Cattell RB, Mosely CH. Combined resection of the stomach and transverse colon for carcinoma; report of two cases. Lahey Clin Bull. 1946;4(8):238-241.
Brunschwig A. Pancreato-total gastrectomy and splenectomy for advanced carcinoma of the stomach. Cancer. 1948;1(3):427-430.
Lawrence W, Jr., McNeer G. An analysis of the role of radical surgery for gastric cancer. Surg Gynecol Obstet. 1960;111:691-696.
DeVita VT, Jr., Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68(21):8643-8653.
Farber S, Diamond LK. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med. 1948;238(23):787-793.
Heidelberger C, Chaudhuri NK, Danneberg P, et al. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature. 1957;179(4561):663-666.
Poon MA, O’Connell MJ, Moertel CG, et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol. 1989;7(10):1407-1418.
Machover D, Schwarzenberg L, Goldschmidt E, et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with highdose folinic acid: a pilot study. Cancer Treat Rep. 1982;66(10):1803-1807.
Madajewicz S, Petrelli N, Rustum YM, et al. Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res. 1984;44(10):4667-4669.
Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol. 1993;11(10):1879-1887.
Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet. 1995;345(8955):939-944.
de Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol. 1997;15(2):808-815.
Kidani Y, Noji M, Tashiro T. Antitumor activity of platinum(II) complexes of 1,2-diamino-cyclohexane isomers. Gan. 1980;71(5):637-643.
Kunimoto T, Nitta K, Tanaka T, et al. Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors. Cancer Res. 1987;47(22):5944-5947.
Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 1971;133(2):275-288.
Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350(23):2335-2342.
Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Mendelsohn J. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci U S A. 1983;80(5):1337-1341.
Lievre A, Bachet JB, Le Corre D, et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res. 2006;66(8):3992- 3995.
Van Cutsem E, Kohne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360(14):1408- 1417.
Dobosz P, Dzieciatkowski T. The Intriguing History of Cancer Immunotherapy. Front Immunol. 2019;10:2965.
Decker WK, da Silva RF, Sanabria MH, et al. Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models. Front Immunol. 2017;8:829.
McCarthy EF. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J. 2006;26:154-158.
Isaacs A, Lindenmann J, Valentine RC. Virus interference. II. Some properties of interferon. Proc R Soc Lond B Biol Sci. 1957;147(927):268-273.
Connell PP, Hellman S. Advances in radiotherapy and implications for the next century: a historical perspective. Cancer Res. 2009;69(2):383-392.
McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys. 2005;63(4):1010- 1015.
Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys. 2005;62(5):1371-1378.
Hoyer M, Roed H, Traberg Hansen A, et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol. 2006;45(7):823-830.
Kardinal CG, Yarbro JW. A conceptual history of cancer. Semin Oncol. 1979;6(4):396-408. 41. Gomez P, Rosado A. History of cancer investigation. Arch Invest Med (Mex). 1981;12(3):361-375.
Cómo citar
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2021 Medicina
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Copyright
ANM de Colombia
Los autores deben declarar revisión, validación y aprobación para publicación del manuscrito, además de la cesión de los derechos patrimoniales de publicación, mediante un documento que debe ser enviado antes de la aparición del escrito. Puede solicitar el formato a través del correo revistamedicina@anmdecolombia.org.co o descargarlo directamente Documento Garantías y cesión de derechos.docx
Copyright
ANM de Colombia
Authors must state that they reviewed, validated and approved the manuscript's publication. Moreover, they must sign a model release that should be sent.